A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Examine the Efficacy of Rizatriptan 10 Mg Tablet Administered Early During a Migraine Attack While the Pain is Mild.
Phase of Trial: Phase III
Latest Information Update: 06 Apr 2017
At a glance
- Drugs Rizatriptan (Primary)
- Indications Migraine
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Merck; Merck Sharp & Dohme
- 12 May 2009 Planned number of patients added as 510 as reported by ClinicalTrials.gov.
- 01 Oct 2005 New trial record.